MRI Using Ferumoxytol Improves the Visualization of Central Nervous System Vascular Malformations
Author(s) -
Edit Dósa,
Suchita Tuladhar,
Leslie L. Muldoon,
Bronwyn E. Hamilton,
William D. Rooney,
Edward A. Neuwelt
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.607994
Subject(s) - ferumoxytol , medicine , arteriovenous malformation , central nervous system , vascular malformation , magnetic resonance imaging , lesion , vascular anomaly , radiology , pathology
Central nervous system vascular malformations (VMs) result from abnormal vasculo- and/or angiogenesis. Cavernomas and arteriovenous malformations are also sites of active inflammation. The aim of this study was to determine whether MRI detection of VMs can be improved by administration of ferumoxytol iron oxide nanoparticle, which acts as a blood pool agent at early time points and an inflammatory marker when taken up by tissue macrophages.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom